Comments for Atamyo Therapeutics https://atamyo.com Changing life of Neuromuscular patients Tue, 10 Feb 2026 16:35:30 +0000 hourly 1 https://wordpress.org/?v=6.7.4 Comment on Atamyo Therapeutics Announces First Patient Dosed with ATA-100 Gene Therapy in LGMD-R9 Clinical Trial by First Patient Dosed in Phase 1/2 Clinical Trial in Europe of Gene Therapy for LGMD-R9 First Patient Dosed in Phase 1/2 Clinical Trial in Europe of Gene Therapy for LGMD-R9 https://atamyo.com/press-releases/atamyo-therapeutics-announces-first-patient-dosed-with-ata-100-gene-therapy-in-lgmd-r9-clinical-trial/#comment-14 Wed, 02 Nov 2022 16:39:48 +0000 https://atamyo.com/?p=714#comment-14 […] ATA-100 is a one-time replacement gene therapy combining an AAV vector and a normal copy of the FKRP gene. The Phase 1/2 clinical trial will assess the safety and efficacy of ATA-100. The first patient was treated by Prof. John Vissing, Director of the Copenhagen Neuromuscular Center at the Rigshospital National Hospital and principal investigator of this study. For more information see Atamyo’s press release. […]

]]> Comment on Atamyo Therapeutics Announces First Patient Dosed with ATA-100 Gene Therapy in LGMD-R9 Clinical Trial by Atamyo doses first subject in Phase I/II muscular dystrophy therapy trial https://atamyo.com/press-releases/atamyo-therapeutics-announces-first-patient-dosed-with-ata-100-gene-therapy-in-lgmd-r9-clinical-trial/#comment-11 Tue, 27 Sep 2022 11:47:24 +0000 https://atamyo.com/?p=714#comment-11 […] Therapeutics has dosed the first subject in a Phase I/II clinical trial of ATA-100 to treat FRKP-related limb-girdle […]

]]> Comment on Atamyo Therapeutics annonce le traitement d’un premier patient avec sa thérapie génique ATA-100 dans l’essai clinique ciblant la myopathie des ceintures LGMD-R9 by Recrutement ouvert pour l’étude de thérapie génique FKRP d'Atamyo - Groupe d'Intérêt LGMD Myopathies des Ceintures https://atamyo.com/press-releases/2022/atamyo-therapeutics-annonce-le-traitement-dun-premier-patient-avec-sa-therapie-genique-ata-100-dans-lessai-clinique-ciblant-la-myopathie-des-ceintures-lgmd-r9/#comment-10 Mon, 26 Sep 2022 13:33:03 +0000 https://atamyo.com/?p=708#comment-10 […] Ça y est, le recrutement est enfin ouvert pour l’étude de thérapie génique FKRP d’Atamyo. Comme vous avez pu le lire dans l’article décrivant ce premier essai de thérapie génique pour la myopathie des ceintures liée au gène FKRP, il s’agit d’une étude de phase I/II. Atamyo Therapeutics a annoncé aujourd’hui, le 26 septembre 2022, le traitement d’un pre… […]

]]>